Dual Chamber Injection Devices Market, 2024

DUBLIN, Dec. 21, 2017 /PRNewswire/ --

The "Dual Chamber Injection Devices to 2024" report has been added to Research and Markets' offering.

As biological drugs continue to grow in terms of therapeutics and total prescriptions, the impact of these specialty devices will increase, reaching a therapeutic market value of $5.3 billion annually in 2024.

The need to reconstitute lyophilized drugs at the point of administration and the potential safety and compliance issues this represents for patients has led to increasing interest in injection devices that can eliminate the number of steps required to reconstitute the drug and make it available for injection.

Dual chamber syringes and injectors - devices that allow reconstitution to take place within the device immediately prior to injection - represent the most elegant engineering solution to this need. While the use of dual chamber devices represents a cost premium for drug marketers relative to competing reconstitution methods such as vial adaptors, it also provides an opportunity for branding.

In terms of market penetration, dual chamber injection devices can be found in seven distinct therapeutic segments. We expect this number to grow as the influence of injectable biologicals on therapeutic practice increases.

What You Will Learn

• What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?
• What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?
• What are the therapeutic demand drivers for user-friendly point-of-use reconstitution devices and what specifically is the potential of dual chamber syringes and injector systems?
• What are the key dual chamber device selection factors, technologies and market development issues?
• What doses the current dual chamber device market look like, who are the market leaders, and what will this market look like in 2024?
• What companies supply dual chamber syringe and injector devices, and what are their product activities, business strategies, and corporate alliances and affiliations?
• How important are pharma-device alliances and design partnerships on dual chamber injection devices?
• What is the impact of economic, technology, and regulatory factors?

Who Should Read this Report

Development

• Drug Developers
• Device Suppliers
• CMO's
• Components/API's
• Clinical Trial Management

Industry

• Pharma Managers
• Biotech Managers
• Drug Marketers
• Industry Strategists
• Financial Analysts
• Management Consultants

Market

• Clinical Managers
• Drug Distributers
• Pharma Regulators
• FDA Consultants
• Managed Care Managers

Key Topics Covered:

1. Executive Summary

• Specialty Injection Device Market Dynamics
• Drug Formulation Evolution
• Specialty Injection Device Demand Drivers
• Chronic Conditions and Self-Administration
• The Growth of Biologicals
• Shifting Patient Demographics
• Drug Economics, Safety and Compliance
• Device Design and Innovation
• Competitive Landscape
• Technology Market Drivers

2. The Dual Chamber Injection Device Analysis

• Dual Chamber Cartridges
• Branded Devices
• Supply Chain
• Commercial Drug Products
• Dual Chamber Injectors
• Branded Devices
• Supply Chain
• Commercial Drug Products
• Dual Chamber Syringes
• Branded Devices
• Supply Chain
• Commercial Drug Products
• Product-Specific Devices
• Product Specific Device Development
• Specialty Devices
• OEM Devices

3. Dual Chamber Therapeutic Segments - Market Data & Forecasts

• Glycemic Control
• Hereditary Conditions
• Hormone Replacement
• Infectious Disease
• Metabolic Conditions
• Oncology
• Reproductive Health
• Other Therapeutic Segments

4. Market Factors

• Device Product Strategies
• Device Economics
• Product Branding
• Direct-to-Consumer Marketing
• Managed Care Trends

5 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/8f52zz/dual_chamber?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716